As one of the worst-hit nations with rising cases of the novel coronavirus, India awaits with baited breath a promising announcement of a vaccine approved by regulatory authorities which have been monitoring the progress of several vaccine candidates. India’s realistic hopes, however, hinge heavily on three to five vaccine candidates. Recent updates have shown India’s […]
Sharing its latest updates on the ongoing trial of Astrazeneca-Oxford vaccine, the Pune-based Serum Institute of India (SII), the world’s largest manufacturer of vaccines by volumes, has said that India will get 60 – 70 million doses of the Oxford vaccine – Covishield – by this December, but the vaccines will come to the market […]
On 21st September, 2020, the Serum Institute of India (SII), the world’s largest producer of vaccine in volumes, started the Phase-III or last and final stage of clinical trials, for the Covid-19 vaccine ‘Covishield’, at the state-run Sassoon General Hospital in Pune, Maharashtra. As per Dr. Muralidhar Tambe, Dean, Sassoon General Hospital, the dose of the […]